Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Mar;13(3):399–404. doi: 10.1128/aac.13.3.399

Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type.

Y Miyamoto, K Takizawa, A Matsushima, Y Asai, S Nakatsuka
PMCID: PMC352252  PMID: 400820

Abstract

We collected 1,353 strains of beta-hemolytic streptococci of groups A, B, C, and G (1,176 strains of which were group A) isolated in 26 institutions throughout Japan in 1972-1974. The strains were grouped and T-typed by our specific group-and T-factor sera, and the minimal inhibitory concentrations of 10 antibiotics were assayed by the standard method. Resistant strains from the above collection were classified according to group, T-type, and drug resistance pattern. Our data on T-types for 1964-1971 and on drug resistance for 1966-1971 were used to interpret the detected long-term variations in T-type and drug resistance. The stepwise acquisition of multiple drug resistance, the difference in resistance pattern between predominant T-types, and the rarity of single-macrolide resistance were demonstrated.

Full text

PDF
399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. EICKHOFF T. C., FINLAND M., WILCOX C. IN VITRO SUSCEPTIBILITY OF GROUP A BETA HEMOLYTIC STREPTOCOCCI TO 18 ANTIBIOTICS. Am J Med Sci. 1965 Mar;249:261–268. doi: 10.1097/00000441-196503000-00002. [DOI] [PubMed] [Google Scholar]
  2. Finland M., Garner C., Wilcox C., Sabath L. D. Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents. Antimicrob Agents Chemother. 1976 Jan;9(1):11–19. doi: 10.1128/aac.9.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Inoue M., Kazawa T., Mitsuhashi S. Antibacterial and inducer activities for tetracycline resistance by its derivates and analogues. Microbiol Immunol. 1977;21(2):59–67. doi: 10.1111/j.1348-0421.1977.tb02808.x. [DOI] [PubMed] [Google Scholar]
  4. KUHARIC H. A., ROBERTS C. E., Jr, KIR BY W. M. Tetracycline resistance of group A beta hemolytic streptococci. JAMA. 1960 Dec 3;174:1779–1782. doi: 10.1001/jama.1960.03030140001001. [DOI] [PubMed] [Google Scholar]
  5. LOWBURY E. J., CASON J. S. Aureomycin and erythromycin therapy for str. pyogenes in burns. Br Med J. 1954 Oct 16;2(4893):914–915. doi: 10.1136/bmj.2.4893.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. LOWBURY E. J., HURST L. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin. J Clin Pathol. 1959 Mar;12(2):163–169. doi: 10.1136/jcp.12.2.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. MOGABGAB W. J., PELON W. An outbreak of pharyngitis due to tetracyclineresistant group A, type 12 streptococci. AMA J Dis Child. 1958 Dec;96(6):696–698. doi: 10.1001/archpedi.1958.02060060698007. [DOI] [PubMed] [Google Scholar]
  8. Misuno K., Hirayama A., Yoshida R. [Drug sensitivity of Streptococcus haemolyticus ecently isolated from patients with scarlet fever with special reference to the advent of an erythromycin-resistant strain]. Kansenshogaku Zasshi. 1972 Mar;46(3):80–82. doi: 10.11150/kansenshogakuzasshi1970.46.80. [DOI] [PubMed] [Google Scholar]
  9. Miyamoto Y., Takizawa K., Matsushima A., Asai Y., Takahashi T. [Transition in the distribution of types of group A streptococci (from April, 1969 to March, 1974) and annual changes of the predominant types in the past 10 years]. Kansenshogaku Zasshi. 1975 Mar;49(3):86–93. doi: 10.11150/kansenshogakuzasshi1970.49.86. [DOI] [PubMed] [Google Scholar]
  10. Miyamura S., Ochiai H., Nitahara Y., Nakagawa Y., Terao M. Resistance mechanism of chloramphenicol in Streptococcus haemolyticus, Streptococcus pneumoniae and Streptococcus faecalis. Microbiol Immunol. 1977;21(2):69–76. doi: 10.1111/j.1348-0421.1977.tb02809.x. [DOI] [PubMed] [Google Scholar]
  11. Okamoto S., Suzuki Y. Chloramphenicol-, dihydrostreptomycin-, and kanamycin-inactivating enzymes from multiple drug-resistant Escherichia coli carrying episome 'R'. Nature. 1965 Dec 25;208(5017):1301–1303. doi: 10.1038/2081301a0. [DOI] [PubMed] [Google Scholar]
  12. Sanders E., Foster M. T., Scott D. Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N Engl J Med. 1968 Mar 7;278(10):538–540. doi: 10.1056/NEJM196803072781005. [DOI] [PubMed] [Google Scholar]
  13. Takizawa K., Akiyama S., Miyamoto Y. Reexamination and characterization of the T-agglutination complex or pattern of Streptococcus pyogenes: preparation of anti-T factor sera. Jpn J Microbiol. 1970 Jul;14(4):269–277. doi: 10.1111/j.1348-0421.1970.tb00524.x. [DOI] [PubMed] [Google Scholar]
  14. Ubukata K., Konno M., Fujii R. Transduction of drug resistance to tetracycline, chloramphenicol, macrolides, lincomycin and clindamycin with phages induced from Streptococcus pyogenes. J Antibiot (Tokyo) 1975 Sep;28(9):681–688. doi: 10.7164/antibiotics.28.681. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES